Change in multiple filtration markers and subsequent risk of cardiovascular disease and mortality

Clinical Journal of the American Society of Nephrology

Volumn 10, Issue 6, 2015, Pages 941-948

  Rebholz, Casey M ^a   Grams, Morgan E ^a,b   Matsushita, Kunihiro ^a   Inker, Lesley A ^c   Foster, Meredith C ^c   Levey, Andrew S ^c   Selvin, Elizabeth ^a,b   Coresh, Josef ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

Cardiovascular disease; Creatinine; Mortality

Indexed keywords

BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; CHOLESTEROL; CHOLESTEROL OXIDASE; CREATININE; CYSTATIN C; GLUCOSE; HIGH DENSITY LIPOPROTEIN; CST3 PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; BODY MASS; BRAIN ISCHEMIA; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; DISEASE COURSE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION; HEART FAILURE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PRECIPITATION; PROTEIN EXPRESSION; RISK FACTOR; SENSITIVITY ANALYSIS; BLOOD; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; COMPARATIVE STUDY; COMPLICATION; GLOMERULUS FILTRATION RATE; KIDNEY; KIDNEY DISEASES; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; TIME FACTOR; UNITED STATES;

BETA 2-MICROGLOBULIN; BIOMARKERS; CARDIOVASCULAR DISEASES; CREATININE; CYSTATIN C; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY DISEASES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; UNITED STATES;

EID: 84930446957     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.10101014     Document Type: Article

References (39)

1. Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ, Arima H, Chadban SJ, Cirillo M, Djurdjev O, Green JA, Heine GH, Inker LA, Irie F, Ishani A, Ix JH, Kovesdy CP, Marks A, Ohkubo T, Shalev V, Shankar A, Wen CP, de Jong PE, Iseki K, Stengel B, Gansevoort RT, Levey AS; CKD Prognosis Consortium: Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA 311: 2518- 2531, 2014
2. Rebholz CM,Grams ME, Matsushita K, Selvin E, Coresh J: Change in novel filtration markers and risk of ESRD [published online ahead of print December 23, 2014]. Am J Kidney Dis 10.1053/j. ajkd.2014.11.009
3. Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ: Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: A pooled analysis of community-based studies. J Am Soc Nephrol 15: 1307-1315, 2004
4. Astor BC, Coresh J, Heiss G, Pettitt D, Sarnak MJ: Kidney function and anemia as risk factors for coronary heart disease and mortality: The Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 151: 492-500, 2006
5. Kottgen A, Russell SD, Loehr LR, Crainiceanu CM, Rosamond WD, Chang PP, Chambless LE, Coresh J: Reduced kidney function as a risk factor for incident heart failure: The atherosclerosis risk in communities (ARIC) study. J AmSocNephrol 18: 1307-1315, 2007
6. ManjunathG, Tighiouart H, IbrahimH,MacLeod B, Salem DN, Griffith JL, Coresh J, Levey AS, Sarnak MJ: Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol 41: 47-55, 2003
7. Matsushita K, Selvin E, Bash LD, Franceschini N, Astor BC, Coresh J: Change in estimated GFR associates with coronary heart disease and mortality. J Am Soc Nephrol 20: 2617-2624, 2009
8. Rifkin DE, Shlipak MG, Katz R, Fried LF, Siscovick D, Chonchol M, Newman AB, Sarnak MJ: Rapid kidney function decline and mortality risk in older adults. Arch Intern Med 168: 2212-2218, 2008
9. Shlipak MG, Katz R, Kestenbaum B, Siscovick D, Fried L, Newman A, Rifkin D, Sarnak MJ: Rapid decline of kidney function increases cardiovascular risk in the elderly. J Am Soc Nephrol 20: 2625-2630, 2009
10. Stevens LA, Coresh J, Greene T, Levey AS: Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 354: 2473-2483, 2006
11. Astor BC, Shafi T, Hoogeveen RC, Matsushita K, Ballantyne CM, Inker LA, Coresh J: Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population. Am J Kidney Dis 59: 653-662, 2012
12. Foster MC, Inker LA, Levey AS, Selvin E, Eckfeldt J, Juraschek SP, Coresh J; CKD Biomarkers Consortium: Novel filtration markers as predictors of all-cause and cardiovascular mortality in US adults. Am J Kidney Dis 62: 42-51, 2013
13. 2-microglobulin: Its significance in the evaluation of renal function. Kidney Int 32: 635- 641, 1987
14. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, Van Lente F, Zhang YL, Coresh J, Levey AS; CKD-EPI Investigators: Estimating glomerular filtration rate fromserum creatinine and cystatin C.N Engl J Med 367: 20- 29, 2012
15. Dharnidharka VR, Kwon C, Stevens G: Serumcystatin C is superior to serumcreatinine as amarker of kidney function:Ameta-analysis. Am J Kidney Dis 40: 221-226, 2002
16. Peralta CA, Katz R, Sarnak MJ, Ix J, Fried LF, De Boer I, PalmasW, Siscovick D, Levey AS, Shlipak MG: Cystatin C identifies chronic kidney disease patients at higher risk for complications. J AmSoc Nephrol 22: 147-155, 2011
17. Peralta CA, Shlipak MG, Judd S,Cushman M, McClellanW, Zakai NA, Safford MM, Zhang X, Muntner P,Warnock D: Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA 305: 1545-1552, 2011
18. Friedman AN, Moe S, FadelWF, Inman M, Mattar SG, Shihabi Z, Quinney SK: Predicting the glomerular filtration rate in bariatric surgery patients. Am J Nephrol 39: 8-15, 2014
19. The ARIC Investigators: The Atherosclerosis Risk in Communities (ARIC) Study: Design and objectives. The ARIC investigators. Am J Epidemiol 129: 687-702, 1989
20. Siedel J, Hägele EO, Ziegenhorn J, Wahlefeld AW: Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 29: 1075-1080, 1983
21. 2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem 28: 1379-1388, 1982
22. Parrinello CM, Grams ME, CouperD, Ballantyne CM,Hoogeveen RC, Eckfeldt J, Selvin E, Coresh J: Calibration of analytes over twenty-five years in the Atherosclerosis Risk in Communities Study. Circulation 129: AP018, 2014
23. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612, 2009
24. White AD, Folsom AR, Chambless LE, Sharret AR, Yang K, Conwill D, Higgins M, Williams OD, Tyroler HA: Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: Methods and initial two years' experience. J Clin Epidemiol 49: 223-233, 1996
25. Rosamond WD, Folsom AR, Chambless LE, Wang CH, McGovern PG, Howard G, Copper LS, Shahar E: Stroke incidence and survival among middle-aged adults: 9-year followup of the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke 30: 736-743, 1999
26. Loehr LR, Rosamond WD, Chang PP, Folsom AR, Chambless LE: Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study). Am J Cardiol 101: 1016-1022, 2008
27. Turin TC, Coresh J, TonelliM, Stevens PE, de Jong PE, Farmer CK, Matsushita K, Hemmelgarn BR: Change in the estimated glomerular filtration rate over time and risk of all-cause mortality. Kidney Int 83: 684-691, 2013
28. Turin TC, Coresh J, TonelliM, Stevens PE, de Jong PE, Farmer CK, Matsushita K, Hemmelgarn BR: One-year change in kidney function is associated with an increased mortality risk. Am J Nephrol 36: 41-49, 2012
29. Perkins RM, Bucaloiu ID, Kirchner HL, Ashouian N, Hartle JE, Yahya T: GFR decline and mortality risk among patients with chronic kidney disease. Clin J Am Soc Nephrol 6: 1879-1886, 2011
30. Kovesdy CP, George SM, Anderson JE, Kalantar-Zadeh K: Outcome predictability of biomarkers of protein-energy wasting and inflammation in moderate and advanced chronic kidney disease. Am J Clin Nutr 90: 407-414, 2009
31. Tonelli M, Klarenbach SW, Lloyd AM, James MT, Bello AK, Manns BJ, Hemmelgarn BR: Higher estimated glomerular filtration rates may be associated with increased risk of adverse outcomes, especially with concomitant proteinuria. Kidney Int 80: 1306-1314, 2011
32. Levin A, DjurdjevO, BeaulieuM, Er L: Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort. Am J Kidney Dis 52: 661-671, 2008
33. Al-Aly Z, Zeringue A, Fu J, Rauchman MI, McDonald JR, El-Achkar TM, Balasubramanian S, Nurutdinova D, Xian H, Stroupe K, Abbott KC, Eisen S: Rate of kidney function decline associates with mortality. J Am Soc Nephrol 21: 1961-1969, 2010
34. Eriksen BO, Ingebretsen OC: The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age. Kidney Int 69: 375-382, 2006
35. Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, Gansevoort RT, Kasiske BL, Eckardt KU: The definition, classification, and prognosis of chronic kidney disease: A KDIGO Controversies Conference report. Kidney Int 80: 17-28, 2011
36. Grubb A, Blirup-Jensen S, Lindström V, Schmidt C, Althaus H, Zegers I; IFCC Working Group on Standardisation of Cystatin C (WG-SCC): First certified reference material for cystatin C in human serumERM-DA471/IFCC. Clin ChemLab Med 48: 1619- 1621, 2010
37. Li L, Astor BC, Lewis J, Hu B, Appel LJ, Lipkowitz MS, Toto RD, Wang X, Wright JT Jr., Greene TH: Longitudinal progression trajectory of GFR among patients with CKD. Am J Kidney Dis 59: 504-512, 2012
38. Li L, Chang A, Rostand SG, Hebert L, Appel LJ, Astor BC, Lipkowitz MS, Wright JT, Kendrick C, Wang X, Greene TH: A within-patient analysis for time-varying risk factors of CKD progression. J Am Soc Nephrol 25: 606-613, 2014
39. Tangri N, Stevens LA, Griffith J, Tighiouart H, Djurdjev O, Naimark D, Levin A, Levey AS: A predictive model for progression of chronic kidney disease to kidney failure. JAMA 305: 1553-1559, 2011